射血分数降低心衰合并心室性继发性二尖瓣反流的整体管理策略
本综述总结射血分数降低心衰(HFrEF)合并继发性二尖瓣反流(SMR)患者的全程管理。指南导向药物治疗(GDMT)和心脏再同步治疗(CRT)可减轻SMR严重程度,但GDMT可能因低血压和肾功能恶化不耐受。成功的二尖瓣经导管缘对缘修复(M-TEER)可增加前向每搏输出量和血压、改善肾脏灌注,从而可能作为GDMT的使能治疗。
要点
- GDMT和CRT均可减轻SMR严重程度。
- M-TEER成功后可改善血流动力学,可能提高GDMT耐受性。
- 即使经导管治疗成功,患者仍处高临床事件风险,需密切随访并持续实施GDMT。
核心结论
- HFrEF合并SMR患者需整合GDMT、器械(CRT)和M-TEER的整体管理,M-TEER可能作为GDMT的使能治疗。
研究设计与样本
- 本文为当前知识综述,总结HFrEF合并心室性SMR患者全程管理(诊断、治疗和随访)。
主要发现
- GDMT和CRT均可减轻SMR严重程度。
- GDMT在HFrEF患者中可能因低血压和肾功能恶化而不耐受。
- 成功的M-TEER可增加前向每搏输出量和血压、改善肾脏灌注,使GDMT在术后可能更好耐受。
- 房颤导管消融和冠状动脉血运重建可能在极选择性患者中发挥作用。
- 即使经导管治疗成功,HFrEF合并SMR患者仍处高临床事件风险。
临床怎么用
- 对HFrEF合并SMR患者应综合考虑GDMT、CRT适应证和M-TEER,注重GDMT在干预前后的持续实施与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optimal management of patients with heart failure with reduced ejection fraction (HFrEF) and secondary mitral regurgitation (SMR) requires the integration of multiple competencies with the interplay of guideline-directed medical therapy (GDMT) for HFrEF, devices, namely cardiac resynchronization therapy (CRT), when indicated, and mitral transcatheter edge-to-edge repair (M-TEER). Both GDMT and CRT can reduce SMR severity. However, GDMT may not be tolerated in patients with HFrEF who develop hypotension and worsening kidney function following uptitration. On the other hand, a successful M-TEER can increase forward stroke volume and blood pressure and improve kidney perfusion so that GDMT may be better tolerated after rather than before this procedure. Thus, similarly to CRT, M-TEER may serve as enabling therapy for GDMT. Notably, catheter ablation for atrial fibrillation and coronary revascularization may have a role in very selected patients. Furthermore, these patients with HFrEF and SMR remain at high risk of clinical events even after successful transcatheter treatments (i.e. M-TEER). Careful follow-up and continuous implementation of GDMT remain a major priority both before and after any intervention. The aim of this state-of-the-art review is to summarize current knowledge about management of HFrEF and ventricular SMR including the entire patient pathway (i.e. diagnosis, treatment and follow-up) with a focus on the effects of GDMT and CRT on SMR as well as on the effects of successful M-TEER on GDMT tolerability.
引用
- Adamo, Pagnesi, Ajmone Marsan, et al. Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach. Eur Heart J. 2026. PMID: 40748645. doi:10.1093/eurheartj/ehaf480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。